Gene Query: SH2D3C

Dataset Description Geneva Score
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 50.7
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 41.01
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 38.33
R430: A potent inbibitor of DNA and RNA viruses 36.74
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 34.44
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 31.42
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 30.77
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 29.86
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 29.3
Selective suppression of endothelial cytokine production by progesterone receptor 29.3
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 27.11
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 25.76
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 25.36
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 24.08
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 23.32
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 22.92
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 22.92
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 22.79
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 22.58
Differentiation enhances Zika virus infection in neuronal brain cells 22.29
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 21.86
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 21.86
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 20.23
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 19.28
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 19.24
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 19.24
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 19.19
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 18.64
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 18.48
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 18.48
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 17.58
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 17.58
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 17.24
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 16.7
Human neutrophil genome during PMA- and E. coli encounter-induced activation 16.7
A Unique Epigenomic Landscape Defines Human Erythropoiesis 16.46
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 16.46
Transcriptome analysis of SKI knock-out in HL60 cells 16.41
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 16.41
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 16.3
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 16.3
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 16.28
Characterization of human ILC2 subsets 16.21
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 15.97
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 14.51
Polarized B -cell functions 14.45
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 14.03
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 13.94
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 13.29
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 13.23
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 13.1
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 13.01
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 12.94
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 12.52
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 12.46
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 12.16
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 12.15
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 12.14
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 12.06
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 12.02
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 12.02
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 11.75
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 11.63
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 11.63
Transcriptome of diurnal human blood neutrophils 11.46
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 11.42
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 11.22
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 11.14
Differentially expressed vascular development genes for iPSC-ECs from CDI 11.0
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 10.88
The human blood-nerve barrier transcriptome 10.57
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 10.48
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 10.26
Expression and functions of long noncoding RNAs during human T helper cell differentiation 10.07
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 9.59
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 9.58
The evolution of N6-methyladenosine in primates 9.52
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 9.49
Regulating Interleukin-2 activity with engineered receptor signaling clamps 9.39
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 9.29
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 9.27
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 9.26
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 9.16
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 9.08
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 8.93
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 8.83
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 8.64
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 8.64
Transcriptome-wide identification of CELF2 functional targets in T cells 8.58
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 8.58
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 8.58
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 8.52
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 8.45
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 8.45
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 8.34
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 8.25
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 8.2
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 8.19
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 8.17
Investigation about fibroblasts of different origins in culture 8.11
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 8.1
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 8.04
mRNA expression profile of Lymphocytes by high-throuput sequencing 8.0
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 7.98
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 7.98
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 7.83
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 7.81
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 7.72
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 7.67
Transcriptional profile in human S. haematobium infection 7.63
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 7.61
Transcriptional profiles of normal human mature B cells 7.61
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 7.53
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 7.5
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 7.47
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 7.37
Non-coding regions are the main source of tumor-specific antigens [human] 7.28
Non-coding regions are the main source of tumor-specific antigens 7.28
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 7.24
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 7.06
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 6.93
Identification of renal resident macrophages across species [C1] 6.72
RNA sequencing with KSHV infection and enrichment for circular RNAs 6.66
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 6.6
Lysine benzoylation is a novel histone mark 6.52
Lysine benzoylation is a novel histone mark [RNA-seq] 6.52
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 6.51
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 6.47
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 6.44
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 6.4
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 6.38
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 6.38
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 6.35
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 6.32
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 6.32
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 6.24
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 6.18
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 6.16
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 6.12
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 6.12
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 6.03
Transcriptome of activated human and mouse MAIT cells 5.98
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 5.91
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 5.89
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 5.89
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 5.86
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 5.82
Global analysis of alternative splicing regulated by RBM10 5.74
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 5.72
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 5.68
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 5.51
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 5.45
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 5.41
Stem and effector CD8 T-cells from human cancers 5.4
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 5.37
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 5.32
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 5.22
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 5.18
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 5.12
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 5.1
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 5.0
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 4.97
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 4.87
Effect of from Human Umbilical Vein Endothelial Cells 4.83
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 4.82
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 4.73
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 4.72
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 4.71
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 4.7
Pharmacologic inhibition of STAT5 in AML 4.7
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 4.58
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 4.58
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 4.58
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 4.52
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 4.5
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 4.5
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 4.43
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 4.42
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 4.41
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 4.4
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 4.4
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 4.35
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 4.34
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 4.33
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 4.3
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 4.29
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 4.27
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 4.23
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 4.22
Leucegene: AML sequencing (part 6) 4.22
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 4.22
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 4.22
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 4.19
Integrating single-cell transcriptomic data across different conditions, technologies, and species 4.16
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 4.15
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.1
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 4.07
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 4.03
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 4.02
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 4.0
BACH2 in human plasma cell fate decision 3.99
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 3.94
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 3.94
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 3.91
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 3.88
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 3.85
naive T cell heterogeneity after neonatal thymectomy 3.82
Transciptomic profiling of human fetal lung samples 3.81
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 3.8
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 3.77
The cytokine environment influence on human skin-derived T cells 3.74
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 3.73
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 3.7
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 3.7
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 3.67
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 3.65
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 3.59
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 3.59
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 3.57
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 3.57
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 3.56
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 3.55
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 3.51
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 3.51
Morphological and molecular characterization of human dermal lymphatic collectors 3.5
Human T-cell lymphoblastic lymphoma samples and control thymuses 3.48
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 3.48
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 3.45
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 3.43
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 3.39
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 3.38
Intron retention induced by microsatellite expansions as a disease biomarker. 3.37
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 3.36
RNA-Seq from human ILC transitional populations 3.3
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 3.3
RNA polymerase in pre-B-ALL cell lines 3.29
Gene expression analysis upon mtDNA depletion 3.29
Gene expression analysis upon mtDNA depletion [RNA-seq] 3.29
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 3.28
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 3.27
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 3.24
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 3.23
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 3.23
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 3.22
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 3.21
MYCi975 regulates MYC target genes 3.2
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 3.19
Total RNA-seq in ALL-SIL upon JQ1 inhibition 3.18
Transcriptomes in healthy and CHB fetal hearts 3.18
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 3.15
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 3.12
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 3.12
mRNA expression profile of Lymphocytes 3.12
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 3.11
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 3.1
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 3.09
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 3.09
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 3.09
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 3.09
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 3.05
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 3.05
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 3.04
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 3.03
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 2.94
An integrative analysis of non-coding regulatory DNA variations associated with autism 2.93
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.91
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.91
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 2.89
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 2.89
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 2.87
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 2.81
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 2.79
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 2.78
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 2.78
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 2.76
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.75
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 2.74
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 2.67
Discovering human diabetes-risk gene function with genetics and physiological assays 2.67
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 2.66
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 2.66
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 2.64
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 2.6
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 2.52
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 2.5
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 2.49
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 2.48
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 2.48
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 2.48
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 2.47
Hijacking of stress response machinery by oncogenes in acute leukaemia 2.47
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 2.47
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 2.45
CD74 role in transcription regulation [RNA-seq] 2.44
CD74 role in transcription regulation 2.44
Targeted enhancer activation by a subunit of the integrator complex 2.39
RNA-Seq and expression data from human adipose tissue 2.39
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.39
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.37
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.37
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 2.32
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 2.32
Gene expression regulated by CSA and CSB in neuroblastoma cell line 2.32
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 2.29
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 2.29
Total RNA sequencing of APC mutant and wt colonic organoids 2.27
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 2.25
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 2.25
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 2.23
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 2.22
An optimization system for isolating and sequencing of single human colon cancer cells 2.2
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 2.18
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 2.16
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 2.16
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 2.14
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 2.14
Statins modulate endothelial transcriptional profile by inhibiting EZH2 2.13
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.13
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 2.13
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 2.12
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 2.11
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 2.09
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 2.07
Transcriptome analysis reveals differential splicing events in IPF lung tissue 2.06
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 2.05
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 2.04
Modulation of nonsense-mediated decay by rapamycin 2.03
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 2.03
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 2.02
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 2.02
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 2.01
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 2.01
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 1.99
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 1.98
Gene expression profile of multiple myeloma cell lines treated with CB-5083 1.96
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 1.95
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 1.92
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 1.88
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 1.87
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 1.87
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 1.85
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 1.83
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 1.83
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 1.79
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 1.78
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 1.75
Be1 and Be2 B cells are transcriptionally distinct 1.73
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 1.73
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 1.67
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 1.67
Endothelial gene expression analysis 1.67
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 1.65
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.64
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 1.63
Widespread intronic polyadenylation diversifies immune cell transcriptomes 1.52
FGF2 regulation of gene expression in stable inducible Neurons 1.49
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 1.48
Gene expression profiling of leukemia cells following asparagine depletion 1.48
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 1.47
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 1.45
iPSC derived motor neuron cultures from C9ORF72 carriers 1.45
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 1.41
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 1.39
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 1.39
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 1.39
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 1.39
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 1.39
RNA sequencing of T-ALL (COG study) 1.38
Analyses of T-ALL (COG study) 1.38
Gene expression profile of CRC-derived HILEC 1.35
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 1.35
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.34
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.33
A novel target of EZH1/2 for treatment of mantle cell lymphoma 1.32
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 1.32
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 1.3
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.29
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.25
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 1.24
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 1.22
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 1.2
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.19
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 1.19
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 1.19
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 1.15
SOX11 knockdown in B-ALL cell lines 1.14
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 1.13
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 1.11
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.11
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.1
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 1.1
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 1.1
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.1
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 1.09
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 1.09
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.09
miR-93 Targets in Human Endothelial Cells 1.08
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 1.08
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.06
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 1.04
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.04
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 1.03
Aging-associated patterns in the expression of human endogenous retroviruses 1.0
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.99
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.98
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.97
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.96
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.93
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 0.92
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 0.92
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 0.92
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.88
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.87
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 0.83
Tpl-2 small molecule project 0.82
Tpl-2 and MEK small molecule inhibitors 0.82
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.82
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.82
Identification of long noncoding RNAs in T-ALL cell lines 0.82
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.81
MAIT cell RNA sequencing 0.8
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.8
RNA-Seq in PWS iPSC-derived neurons 0.78
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 0.77
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.75
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.74
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 0.73
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.72
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 0.7
Total RNA-Seq data from leukemic patients with complex structural variants 0.7
Gene expression activation in CLL mediated by MSCs contact 0.7
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 0.68
The role of m6A/m-RNA methylation in stress response regulation 0.67
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.67
CD86 regulates a pro-survival signal in myeloma cells 0.67
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.66
Reprogrammed myeloid cell transcriptomes in NSCLC 0.66
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 0.65
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 0.65
Dermal endothelial cells of type 2 diabetic patients 0.64
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 0.63
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.59
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.59
Primary Human B-cell Temporal Response to CD40L Stimulation 0.58
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 0.56
Expression patterns in chronic thromboembolic pulmonary hypertension 0.55
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 0.53
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 0.53
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 0.53
Genome-wide Analysis of Chromatin Interactions in Human Cells 0.52
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.51
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.51
A map of gene expression in neutrophil-like cell lines 0.5
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.5
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.5
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 0.49
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 0.49
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.49
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.47
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.47
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.47
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.46
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.46
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.46
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.44
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 0.44
Bone marrow derived human B cells [normal proB] 0.44
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.44
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 0.41
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 0.41
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.39
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.38
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.36
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.36
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.34
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.3
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  0.28
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.26
Leucegene: ALL sequencing 0.26
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 0.26
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.25
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.22
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.21
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 0.21
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 0.2
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.2
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.2
Specific molecular signatures underlie response to decitabine in CMML 0.16
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.16
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.14
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.12
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 0.11
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.11
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.11
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.1
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.07
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 0.07
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.05
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.04
Identification of renal resident macrophages across species 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation